Level Up: Leveraging AI for Drug Discovery as a Biology Startup

Artificial Intelligence for healthcare is here to stay. Machine learning and AI have made it possible to search and develop new pharmaceuticals, faster, cheaper, and more effectively. [1]

If you have a biology startup, it may seem obvious to leverage the power of AI to speed up your research – but just because you can, doesn’t mean you should. On October 1, two AI companies partnering with biology startups will present their views on:

·        How to build AI into your biotech  company and how to start

·        How to determine the right timing for integrating AI as a tool

·        How to create effective partnerships with big and small to vertically integrate

·        How AI companies doing in silico research can employ biology to quickly and efficiently validate research

Following the presentations, Emma Huang, Director of Data Sciences External Innovation, Johnson & Johnson Innovation, will join the companies for a panel discussion on what big pharma has seen, what they’re looking for, and how startups can differentiate themselves.

_{Source: [1]https://www.nature.com/articles/d41586-018-05267-x}